A detailed history of Garrett Wealth Advisory Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Garrett Wealth Advisory Group, LLC holds 1,451 shares of ABBV stock, worth $262,834. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,451
Holding current value
$262,834
% of portfolio
0.07%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$163.84 - $199.33 $237,731 - $289,227
1,451 New
1,451 $286,000
Q4 2019

Jan 28, 2020

SELL
$72.13 - $90.25 $47,822 - $59,835
-663 Closed
0 $0
Q3 2019

Oct 18, 2019

BUY
$62.98 - $75.72 $41,755 - $50,202
663 New
663 $50,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $320B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Garrett Wealth Advisory Group, LLC Portfolio

Follow Garrett Wealth Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Garrett Wealth Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Garrett Wealth Advisory Group, LLC with notifications on news.